Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:14884/feed
Other Conditions
Vol. 2, Issue 1, 2014August 06, 2014 EDT

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence

Aaron Galaznik, Katherine Cappell, Leslie Montejano, Geoffrey Makinson, Kelly H. Zou, Gregory Lenhart,
vareniclineutilizationsmoking cessationout-of-pocket
Copyright Logoccby-4.0 • https://doi.org/10.36469/9888
Photo by A B E D K A Y A L I on Unsplash
JHEOR
1.
Galaznik A, Cappell K, Montejano L, Makinson G, Zou KH, Lenhart G. Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence. JHEOR. 2014;2(1):53-62. doi:10.36469/​9888
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system